The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI US$ 22.55 Min. order: 1 piece ★★★★★ 4.9 (13 reviews) Sold : Login>>
Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment US$ 23.22 Min. order: 1 piece ★★★★★ 4.0 (55 reviews) Sold : Login>>